Severe Nasal Congestion Liquid
NDC Package 0363-9351-75

11-digit billing NDC: 00363935175
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Severe Nasal Congestion (oxymetazoline spray) liquids is to Use: Shake well before use. This formulation utilizes a liquid delivery system. Marketed by Walgreens Company, this product is identified by NDC 0363-9351 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
0363-9351-75
Package Description
1 BOTTLE, PUMP in 1 CARTON / 22 mL in 1 BOTTLE, PUMP
Product Code
0363-9351
11-Digit Billing Format
00363935175

Clinical Specifications

Proprietary Name
Severe Nasal Congestion
Non-Proprietary Name
Oxymetazoline Spray
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE 50 mg/100mL
Pharmacologic Class
Usage Information
To Use: Shake well before use. Squeeze groves on both side of the cap and twist counter clockwise. Align the lines on the groove at the base of the pump to enable spray. Before using the first time, prime metered pump by depressing pump firmly several times. To spray, hold thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm and even stroke and sniff deeeply. Wipe nozzle clean after use. Secure cap after use. adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril, not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.children under 6 years of age: consult a doctor.

Regulatory & Marketing

Labeler Name
Walgreens Company
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-10-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0363-9351-75 identifies a specific commercial package of 1 bottle, pump in 1 carton / 22 ml in 1 bottle, pump of Severe Nasal Congestion, a human over the counter drug labeled by Walgreens Company. This liquid is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens Company on July 10, 2026. The current certification is valid through December 31, 2027.

How is this Walgreens Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363935175. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0363-9351-75
11-Digit CMS (5-4-2)
00363-9351-75

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.